For pro-life advocates who have long warned that chemical abortions would become the next battleground after Roe v. Wade, Sen. Josh Hawley (R-MO) is signaling that the fight has finally arrived in Washington.
According to RedState, Hawley has introduced legislation that would revoke the Food and Drug Administrations approval of mifepristone, the abortion pill that now sits at the center of the post-Roe landscape. The proposal would force a direct clash between Congress and a federal bureaucracy that signed off on the drug more than twenty years ago, even as its use has quietly transformed the abortion industry.
Medication abortion now accounts for roughly 63 percent of abortions nationwide, according to data cited in reporting on the legislation. What was once a relatively limited method has become the dominant practice, deepening frustration among pro-life Americans who believe federal regulators and lawmakers have been slow to confront the shift.
For these advocates, the end of Roe did not resolve the moral and legal struggle over abortion; it redirected it. Instead of focusing primarily on brick-and-mortar clinics, the conflict now centers on pills prescribed via telehealth and shipped through the mail, often across state lines with minimal oversight.
Hawley contends that this evolution has created a direct collision between federal drug policy and state-level protections for the unborn enacted after Roe was overturned. Weve known for years that mifepristone is risky but its really just in the last few years that weve learned that this drug is inherently dangerous and it is inherently prone to abuse, Hawley said while discussing the legislation.
The Missouri senator also cited research he argues shows the dangers are far greater than the FDA has admitted. What it means in practice is internal infections, sepsis, a trip to the emergency room, a life-threatening condition, in 11 percent of cases, he said, referencing research examining hundreds of thousands of prescriptions.
Where abortion once largely took place in clinics under direct medical supervision, it can now begin with an online consultation and end with pills dropped in a mailbox. That transformation has made enforcement far more difficult for states seeking to protect unborn life and has renewed scrutiny of the federal agencies that approved and continue to regulate these drugs.
Hawley and other pro-life lawmakers argue that telemedicine prescriptions and interstate shipment of abortion pills have invited widespread misuse while undermining state sovereignty and the rule of law. The legislation faces an uncertain future in a narrowly divided Senate, but its introduction underscores how the debate has shifted from surgical procedures to the chemical agents that now drive most abortions in America.
For decades, abortion policy assumed a doctor, a clinic, and a physical procedure; medication abortion has shattered that model and moved the fight to the realm of pharmaceuticals and federal regulators. Medication abortion now drives the majority of abortions in the United States, and Hawleys bill goes straight after the drug itself.
Login